MPLT Reports IRIS Study Results
MapLight announces topline results from Phase 2 IRIS study for ML-004 in Autism Spectrum Disorder
MPLT - MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
MapLight announces topline results from Phase 2 IRIS study for ML-004 in Autism Spectrum Disorder
MPLT - MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder